We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -2.35% | 20.75 | 20.50 | 21.00 | 21.25 | 20.75 | 21.25 | 653,988 | 12:42:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.49 | 54.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/10/2022 11:52 | amaretto1. Filtered | tday | |
11/10/2022 11:44 | Because I'm not supposed to know ..I've added today !! | amaretto1 | |
11/10/2022 11:41 | what cant you say who is shorting it? | hsdeo | |
11/10/2022 11:15 | You're the one losing money. Kermithttps://m.yout | 1liam | |
11/10/2022 10:56 | Thats not the point muppet. I would explain but doubt your tiny brain could keep up | zeus19 | |
11/10/2022 10:55 | Won't be long Co Co | 1liam | |
11/10/2022 10:55 | It's been shorted down by ..... i do know... but can't say Andrew Newland is going to blow your balls off !!! Tight ship .. GL | amaretto1 | |
11/10/2022 09:56 | Didnt you say close below 61 yesterday. CLOWN | zeus19 | |
11/10/2022 09:47 | Into the 50s by close | 1liam | |
11/10/2022 09:44 | Far from it, that's when U buy :)Still can't work it out can you!https://m.youtub | 1liam | |
11/10/2022 09:35 | You were a bit quite yesterday when EUA was down 12% TOOL | zeus19 | |
11/10/2022 09:34 | Amaretto adding when he said this will drop to 50p?? What a load of BS !!Feet up and relaxed EUA up 9% Have some ice ameretto dilution is coming. | 1liam | |
11/10/2022 09:04 | Give it a rest, you're becoming extremely monotonous | asdb9 | |
11/10/2022 09:03 | Yes they said that EVG ... it then went up 150 percent in one day Liam !How's your EUA ? U must be suicidal on that one guru | amaretto1 | |
11/10/2022 08:56 | In the absence of any positive news/deals I think there’s a significant drop coming for those wanting to take a punt. | antonagis | |
11/10/2022 08:38 | Just added ... odviously red | amaretto1 | |
10/10/2022 20:00 | Whilst we're on the subject of undervalued Biotechs, what about ARIX Bioscience? Last reported net assets of £1.78p a share made up of £130m in net cash and a further £100m in public and private investments all for a market cap of just £134m! Just the other day the Chairman bought over £100k's worth of shares. The reality is there has been a huge sell off in this sector and I think this has thrown up some cracking opportunities including AGL post FDA. I'll certainly take a look at those two SK, Destiny looks particularly interesting. | arthur_lame_stocks | |
10/10/2022 19:48 | Well,Astra Zeneca, Roche and of course Abbott are companies that I believe are key targets for Her 2 testing so interesting to see how Abbotts desire for exclusivity pans out. | jelenko | |
10/10/2022 19:41 | Despite the price at which it was done, at least they did raise cash when needed. I can't say I'm not disappointed/surpris Regardless I'd rather be in that out and hold about 5% weighting here. | waterloo01 | |
10/10/2022 19:24 | With the full accreditation of the labs and the conversion of some of the 20+ customers in the pipeline this should fly again Crazy low price at the moment given the FDA approval and the fact that the nearest competitor hasn't even filed with the FDA for approvalThis is ground breaking technology. Just add a big of patiencehttps://www. | jsforum | |
10/10/2022 18:35 | TDay, all biotech stocks have been suffering. This is nothing specific to Angle. Many with crazily low share prices. I could give a long list. The point being that there is nothing unique to Angle's management about the performance of the share price this year: - Destiny Pharma, 2x Phase 3 ready drugs, expected to partner the first this quarter, valued at sub £12m per drug. Look at EVG today get a 152% rise (2.5x rise) on what was ultimately an ok licensing deal. Then look at Destiny which is ready to license and which is expected to license this quarter. It is clearly undervalued and seeing Evgen perform today bodes well for the coming weeks there, albeit it is high risk like every other biotech stock. - RUA Life Sciences, market cap just £9m, despite having revenues of £1.625m, and being only one relatively small, confirmatory trial away from being able to make a 510k application for approval for its large bore vascular grafts (which are designed to eliminate the need for animal tissue as a sealant). The market size is $1bn/year. Its heart valve technology being developed, but an an earlier stage, is also very exciting (again using non-animal products but with none of the disadvantage of existing mechanical valves). They have been in discussions with an industry leader in heart valves to see if they can work together. - You could add Evgen before today and look at them fly today. The point of the above is this. You can sit here and criticise the AGL management, or those at DEST or RUA for all the mistakes they have made. No one of course is perfect. Or you can consider that the core company is very strong and take this golden opportunity to buy shares in undervalued companies at ridiculous sector low prices. And unlike the two companies above, Angle does not need cash for 2023, and it is ready to commercialise, with 20+ companies, 3 household names in contract discussions and with Abbott discussions now detailed and progressing very well, plus Baillee Gifford buying in recently at 80p and Aegon buying in since then too. As ever dyor and aimho. | sicilian_kan | |
10/10/2022 18:04 | Selling your shares for a Big Mac! | 1liam | |
10/10/2022 17:28 | Worrying times if this falls below 60p which now appears to be an absolute certainty in the absence of positive news/deals as I fear it will then slide quickly towards 50p or below as mentioned last week. To avoid following most other AIM stocks before it a deal or deals need to be tied up this year, that's for sure. | antonagis | |
10/10/2022 16:43 | https://youtu.be/2So | zeus19 | |
10/10/2022 16:41 | https://m.youtube.co | 1liam |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions